ATTBF News and Press, Abattis Bioceuticals Corp

After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (“ Abattis ” or the “ Company ”) (OTC: AT...

Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...

Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...

Both Senate seats went to Democrats and this allows for a blue agenda with cannabis legalization being one of the top priorities. Arizona's legalization of recreational cannabis is already being geared up for with companies retooling in preparation. The industry will see continued...

2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...

VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis “) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company ...

VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) announces the filing of its annual financial statements for the year ended September 30, 2018 and is pleased to provide...

VANCOUVER, British Columbia, May 21, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated April 2 nd , 2019, the Company’s wholly-owned subsidiary, 1185277 B...

OTC listed Abattis Bioceuticals ( OTCQB:ATTBF +33.3% ) agrees to acquire Pro Natura, a privately held nutraceutical company based in Netherlands, from Catalyst Investment Capital, for ~€17M including ~€10M as milestone payments More news on: Abattis Bioceut...

Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates Canada NewsWire VANCOUVER, British Columbia, April 2, 2019 VANCOUVER, British Columbia , April 2, 2019 /CNW/ --   Abattis Bioceuticals Corp. (the " Company " or " Abat...